VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
BRO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
BROBrown & Brown, Inc.
$59.91$20.0B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksBROFinancials

Brown & Brown, Inc. (BRO) Income Statement

30Y historyFree accessUpdated daily

Revenue accelerated 34.2% YoY in 2026Q2, with the combined ratio improving to 66.2%, though EPS missed estimates by 22% ($0.84 vs $1.08), suggesting possible one-time charges.

Income StatementBalance SheetCash FlowRatios

BRO Income Statement

Annual statement

BRO Income Statement

Brown & Brown, Inc. (BRO) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Revenue6.85B5.96B4.71B4.2B3.56B3.05B2.61B2.38B2.01B1.86B1.76B1.66B1.57B1.36B1.19B1.01B966.92M967.88M977.55M959.67M878M785.81M646.93M546.72M455.74M365.03M265.4M188.39M171.49M143.5M128.16M
Revenue Growth %39.58%26.59%12.05%17.85%16.92%16.94%9.28%18.65%8.22%5.36%6.39%5.71%15.64%14%18.2%4.04%-0.1%-0.99%1.86%9.3%11.73%21.47%18.33%19.96%24.85%37.54%40.88%9.86%19.5%11.97%20.49%
Medical Costs & Claims2.81B734M2.41B2.19B1.82B1.64B1.44B1.31B1.07B994.65M925.22M856.95M811.11M683M608.51M508.68M487.82M0000374.94M0268.37M00000028.08M
Medical Cost Ratio %40.98%12.32%51.14%52.08%51%53.71%55.12%54.86%53.18%53.55%52.49%51.72%51.75%50.39%51.17%50.57%50.45%0%0%0%0%47.71%0%49.09%0%0%0%0%0%0%21.91%
Gross Profit4.04B5.22B2.3B2.01B1.75B1.41B1.17B1.08B940.94M862.62M837.57M800M756.35M672.5M580.58M497.29M479.1M967.88M977.55M959.67M878M407.18M646.93M278.34M455.74M365.03M265.4M188.39M171.49M143.5M100.08M
Gross Margin %59.02%87.68%48.86%47.92%49%46.29%44.88%45.14%46.82%46.45%47.51%48.28%48.25%49.61%48.83%49.43%49.55%100%100%100%100%51.82%100%50.91%100%100%100%100%100%100%78.09%
Gross Profit Growth %-127.14%14.26%15.23%23.78%20.59%8.65%14.41%9.08%2.99%4.7%5.77%12.47%15.83%16.75%3.8%-50.5%-0.99%1.86%9.3%115.63%-37.06%132.42%-38.93%24.85%37.54%40.88%9.86%19.5%43.38%19.98%
Operating Expenses2.09B3.53B932M856M783M555.9M500.8M505.8M441.5M391.61M370.54M359.37M339.16M303.7M269.2M222.42M206.78M698.52M690.37M634.34M584.61M152.26M432.83M102.56M316.42M268.85M210.07M143.55M-42.1M-36.61M71.75M
OpEx / Revenue %30.55%59.22%19.81%20.39%21.98%18.24%19.22%21.21%21.97%21.09%21.02%21.69%21.64%22.4%22.64%22.11%21.39%72.17%70.62%66.1%66.58%19.38%66.9%18.76%69.43%73.65%79.15%76.2%-24.55%-25.51%55.98%
Depreciation & Amortization493M367M222M206M186M152.9M134.8M128.72M109.38M108.14M107.67M108.31M103.84M85.42M78.95M67.15M64.08M63.1M59.92M53.2M47.81M43.31M31.06M25.67M21.29M22.4M15.38M12.24M9.82M8.83M5.21M
Combined Ratio %71.53%71.54%70.95%72.47%72.97%71.95%74.33%76.07%75.15%74.64%73.51%73.41%73.38%72.79%73.81%72.68%71.84%72.17%70.62%66.1%66.58%67.09%66.9%67.85%69.43%73.65%79.15%76.2%-24.55%-25.51%77.89%
Operating Income1.95B1.7B1.37B1.16B963M854.7M668.9M570.77M499.45M471M467.03M440.63M417.18M368.81M311.38M274.87M272.32M269.35M287.19M325.33M293.4M258.6M214.1M175.78M139.32M96.18M55.33M44.84M213.59M180.11M28.33M
Operating Margin %28.47%28.46%29.05%27.53%27.03%28.05%25.67%23.93%24.85%25.36%26.49%26.59%26.62%27.21%26.19%27.32%28.16%27.83%29.38%33.9%33.42%32.91%33.1%32.15%30.57%26.35%20.85%23.8%124.55%125.51%22.11%
Operating Income Growth %-23.99%18.25%20.04%12.67%27.78%17.19%14.28%6.04%0.85%5.99%5.62%13.12%18.44%13.28%0.94%1.1%-6.21%-11.72%10.88%13.46%20.78%21.8%26.17%44.86%73.83%23.4%-79.01%18.58%535.68%7395.77%
EBITDA2.44B2.06B1.59B1.36B1.15B1.01B803.7M699.48M608.83M579.15M574.7M548.94M521.02M454.22M390.32M342.01M336.4M332.45M347.11M378.53M341.2M301.9M245.16M201.45M160.61M118.58M70.71M57.07M223.4M188.94M33.54M
EBITDA Margin %35.67%34.62%33.77%32.44%32.25%33.06%30.84%29.33%30.29%31.18%32.6%33.13%33.24%33.51%32.83%34%34.79%34.35%35.51%39.44%38.86%38.42%37.9%36.85%35.24%32.48%26.64%30.29%130.28%131.67%26.17%
Interest Expense300M297M201M197M148M65M59M63.66M40.58M38.32M39.48M39.25M28.41M16.44M16.1M14.13M14.47M14.6M14.69M13.8M13.36M14.47M7.16M3.62M0000000
Non-Operating Income19M27M-137M-187M-61M26.9M-14.2M-18.82M-3.6M-17.03M4.05M-1.17M49.03M-5.24M-9.53M-9.79M-8.25M000000-4.33M0000000
Pretax Income1.55B1.37B1.3B1.15B876M762.8M624.1M525.93M462.46M449.72M423.5M402.56M339.75M357.61M304.81M270.52M266.1M254.75M272.5M311.53M280.04M244.13M206.95M176.48M134.66M90.48M54.06M44.01M38.6M30.98M27.36M
Pretax Margin %22.59%23.02%27.69%27.29%24.59%25.03%23.95%22.05%23.01%24.21%24.02%24.3%21.68%26.38%25.63%26.89%27.52%26.32%27.88%32.46%31.9%31.07%31.99%32.28%29.55%24.79%20.37%23.36%22.51%21.59%21.35%
Income Tax336M304M301M275.6M204.3M175.7M143.6M127.42M118.21M50.09M166.01M159.24M132.85M140.5M120.77M106.53M104.35M101.46M106.37M120.57M107.69M93.58M78.11M66.16M49.27M34.83M20.15M17.04M15.04M12M10.6M
Effective Tax Rate %21.71%22.17%23.1%24.05%23.32%23.03%23.01%24.23%25.56%11.14%39.2%39.56%39.1%39.29%39.62%39.38%39.21%39.83%39.04%38.7%38.46%38.33%37.74%37.49%36.59%38.5%37.26%38.71%38.96%38.72%38.72%
Net Income1.21B1.05B993M870.5M671.8M587.1M480.5M398.51M344.25M399.63M257.49M243.32M206.9M217.11M184.04M164M161.75M153.29M166.12M190.96M172.35M150.55M128.84M110.32M83.12M53.91M32.79M26.79M23.56M18.99M16.77M
Net Margin %17.59%17.7%21.11%20.73%18.85%19.26%18.44%16.71%17.13%21.52%14.61%14.68%13.2%16.02%15.48%16.3%16.73%15.84%16.99%19.9%19.63%19.16%19.92%20.18%18.24%14.77%12.36%14.22%13.74%13.23%13.08%
Net Income Growth %19.78%6.14%14.07%29.58%14.43%22.19%20.57%15.76%-13.86%55.2%5.82%17.6%-4.71%17.97%12.23%1.39%5.52%-7.72%-13.01%10.8%14.48%16.85%16.79%32.72%54.18%64.4%22.41%13.7%24.09%13.25%13.3%
EPS (Diluted)3.553.163.463.052.372.071.691.401.221.410.910.850.710.740.630.560.560.540.590.680.610.540.470.400.310.210.070.120.050.060.01
EPS Growth %-2.87%-8.67%13.44%28.69%14.49%22.49%20.71%14.75%-13.48%54.95%7.06%19.72%-4.05%17.46%12.5%0%3.7%-8.47%-13.24%11.48%12.96%14.89%17.5%29.03%47.62%216.74%-44.75%131.21%-10.36%366.94%13.76%
EPS (Basic)-3.403.483.072.382.081.701.421.241.430.920.860.720.750.640.570.570.540.590.680.620.550.470.410.310.220.070.080.050.060.01
Diluted Shares Outstanding339M313M284M280.8M278.6M277.41M275.87M274.62M282.21M277.59M275.61M280.22M285.78M285.25M284.02M280.53M278.64M275.01M283.12M272.71M282.04M279.55M277.78M275.59M272.17M252.89M494.61M338.97M454.08M327.34M135.51M

Key Metrics

Growth RegimeAccelerating
ProfitabilityStable
Balance SheetHealthy
Cash FlowRobust
Top Statement Risk

EPS miss and integration costs

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Premium Growth Accelerates on Hard Market

Revenue surged 34.2% year-over-year in 2026Q2, per the latest income statement, reflecting sustained hard market conditions and the GRP acquisition, though organic growth may be decelerating.

The 34.2% top-line growth in 2026Q2, while impressive, includes contributions from the GRP acquisition, masking underlying organic momentum. Sequential revenue declined from $1.9B in 2026Q1 to $1.7B in 2026Q2, suggesting a potential plateau in premium rate increases. Investors should monitor whether the hard market is peaking, as commission growth may moderate if pricing power fades.

Underwriting Profitability Remains Solid

The combined ratio improved to 66.2% in 2026Q2 from 72.0% in the prior quarter, as reported in financial statements, indicating strong underwriting discipline despite rising claims costs.

The combined ratio of 66.2% in 2026Q2 is exceptionally low, reflecting the brokerage model's low risk-bearing nature. However, the loss ratio jumped to 50.0% from 47.7% sequentially, suggesting claims inflation or reserve strengthening. The expense ratio appears well-controlled, but wage inflation remains a key margin risk, as compensation is the largest cost line.

Reserve Releases Bolster Earnings

Loss ratios have been volatile, with 2025Q4 showing a 16.2% loss ratio versus 49.4% in 2025Q3, per SEC filings, implying significant prior-year reserve releases that may be flattering current earnings.

The dramatic fluctuation in loss ratios, particularly the 16.2% in 2025Q4, suggests that reserve releases are smoothing earnings. While this is common in insurance, the magnitude warrants scrutiny. If reserve releases are masking underlying deterioration in current accident year loss ratios, future earnings could be pressured. Investors should assess the quality of reserve development in the footnotes.

Fiduciary Income Lifts Bottom Line

Investment income is not separately disclosed, but fiduciary interest income likely contributed to the 9.0% EPS growth in 2026Q2, as per the income statement, benefiting from higher interest rates.

Although investment income is not broken out, the company's fiduciary cash balances generate interest income that flows through other income. In a high-rate environment, this provides a high-margin boost. However, if rates decline, this tailwind could reverse, pressuring net income. The lack of disclosure limits visibility, but the impact is likely material given the $1.079B cash balance.

Expense Ratio Stable Amid Scale

The expense ratio, implied by the combined ratio, remained near 16-20% in recent quarters, as per financial statements, indicating stable operating leverage despite rapid growth.

The expense ratio appears well-controlled, with the combined ratio consistently below 80% except for 2024Q4. This suggests that the company is achieving scale benefits from acquisitions, but the recent EPS miss (0.84 vs 1.08 estimate) may indicate rising integration costs or wage inflation. Investors should watch for any uptick in the expense ratio as a sign of margin compression.

EPS Miss Raises Earnings Quality Concerns

The 22% EPS miss in the latest quarter, with actual EPS of $0.84 versus $1.08 estimate, as reported in recent filings, suggests possible one-time charges or margin pressures not yet fully explained.

The significant EPS miss in 2026Q2, despite strong revenue growth, is a red flag. It could be due to acquisition-related costs from GRP, higher compensation expenses, or a one-time charge. The CEO's optimistic tone contrasts with the numbers, warranting further investigation. If the miss reflects structural margin erosion, the market may need to reprice the stock. Investors should monitor the next quarter's results for clarity.

BRO — Frequently Asked Questions

Quick answers to the most common questions about buying BRO stock.

What was Brown & Brown, Inc.'s (BRO) revenue in 2025?

For fiscal year 2025, Brown & Brown, Inc. (BRO) reported total revenue of $5.96B. This represents a 4547.3% increase compared to $128.2M in 1996.

Is Brown & Brown, Inc. (BRO) profitable?

Brown & Brown, Inc. (BRO) is profitable, generating $1.05B in net income for the fiscal year ending 2025 with a net profit margin of 17.7%.

What is Brown & Brown, Inc.'s operating profit margin?

Brown & Brown, Inc. (BRO) reported an operating income of $1.70B, resulting in an operating profit margin of 28.5%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Brown & Brown, Inc.'s gross profit and gross margin?

Brown & Brown, Inc. (BRO) generated $5.22B in gross profit for the year, representing a gross profit margin of 87.7%. This demonstrates the company's core pricing power and production efficiency.